​

Our Clinical Trials Department is a crucial part of our medical retina clinic, providing patients with access to the latest and most innovative treatments for retinal conditions. Our team of experienced professionals works closely with leading researchers and industry partners to design and execute clinical trials that are aimed at advancing the field of retina medicine.

 

Our trials encompass a wide range of conditions, including age-related macular degeneration, diabetic retinopathy, and other retinal diseases. Our goal is to evaluate the safety and efficacy of new treatments, and to provide our patients with access to cutting-edge treatments that are not yet widely available. We work closely with industry partners to develop and explore the role of machine learning and artificial intelligence in our clinical research program to help improve patient outcomes.

​

We are dedicated to providing our patients with the highest level of care and prioritize their safety at all times. Our clinical trials are conducted in accordance with the highest ethical and regulatory standards, and our patients are carefully screened and monitored throughout the trial process. Our patients also have the opportunity to contribute to scientific discovery by participating in our trials, and they benefit from being among the first to receive access to innovative treatments.